Literature DB >> 7166673

[2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide].

M Okada, K Imamura, T Fuchigami, T Omae, M Iida, F Nanishi, M Murakami, H Ohgushi, T Yao, K Fujita, K Ogawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7166673

Source DB:  PubMed          Journal:  Nihon Naika Gakkai Zasshi        ISSN： 0021-5384


× No keyword cloud information.
  8 in total

Review 1.  Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature.

Authors:  Ramy H Bishay; Kirtan Ganda; Markus J Seibel
Journal:  Ther Adv Endocrinol Metab       Date:  2016-11-21       Impact factor: 3.565

2.  Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF.

Authors:  Jonathan A Wheeler; Erica L Clinkenbeard
Journal:  Curr Mol Biol Rep       Date:  2019-01-25

Review 3.  New Therapies for Hypophosphatemia-Related to FGF23 Excess.

Authors:  Diana Athonvarangkul; Karl L Insogna
Journal:  Calcif Tissue Int       Date:  2020-06-05       Impact factor: 4.333

Review 4.  Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome.

Authors:  John A Glaspy; Myles Wolf; William E Strauss
Journal:  Adv Ther       Date:  2021-05-30       Impact factor: 3.845

Review 5.  Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice.

Authors:  Edyta Tulewicz-Marti; Andrzej Moniuszko; Grażyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2017-12-14

6.  Severe hypophosphataemia after intravenous iron administration.

Authors:  Gurpreet Anand; Christoph Schmid
Journal:  BMJ Case Rep       Date:  2017-03-13

Review 7.  Upstream Regulators of Fibroblast Growth Factor 23.

Authors:  Danielle M A Ratsma; M Carola Zillikens; Bram C J van der Eerden
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-26       Impact factor: 5.555

8.  Severe Hypophosphatemia Occurring After Repeated Exposure to a Parenteral Iron Formulation.

Authors:  Keerthana Haridas; Alice Yau
Journal:  Case Rep Endocrinol       Date:  2022-10-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.